H
To address the need for an administrative data-based measure that identifies readmissions more likely to be avoidable, 3M Health Information Systems developed the Potentially Preventable Readmissions software (3M-PPRS). A PPR is defined as a readmission that is clinically related to care received during or after the previous hospitalization within a particular time-frame and that could have been prevented by: " [providing] quality care in the initial hospitalization; adequate discharge planning; adequate postdischarge follow-up; [or] coordination between inpatient and outpatient healthcare teams." 7 Clinician panels operationalized this clinical relatedness definition by matching All Patient Refined-Diagnosis Related Group codes from the index admission and subsequent readmission. 7 Non-PPR readmissions are considered less likely to be preventable because (1) they are not clinically related or (2) they are clinically related, but have low preventability (eg, a patient with an AMI admission readmitted with a stroke). 7 Little is known about the extent to which these matched admissions-readmissions signal deficiencies in quality or processes care and are thus potentially preventable or whether this measure performs better than an all-cause readmission measure such as CMS'. Although hospital-level studies have found differences between CMS and 3M-PPRS readmission measures with respect to outlier identification for public reporting and pay-for-performance, which measure more accurately reflects quality of care has not been examined. 8, 9 Nevertheless, State Medicaid programs are increasingly implementing the 3M-PPRS for public reporting and hospital payment. 10, 11 Although both CMS and 3M-PPRS readmission measures are meant for hospital-level comparisons, hospitals with high rates require patient-level preventability information to focus quality improvement activities. Therefore, we wanted to know whether the 3M-PPR software provided additional benefit for this purpose compared with using an all-cause readmission measure such as CMS'. Because software-flagged PPR cases are considered more preventable, we hypothesized that they would experience more process-ofcare failures than unflagged cases. However, we previously found a weak inverse relationship between positive PPR status and process of care failures in pneumonia readmissions. 12 Herein, we expand on this work, examining this association in AMI and HF readmissions (1 acute and 1 chronic cardiovascular condition, respectively).
Methods

Study Design
This was a retrospective cross-sectional study using VA administrative and electronic medical record (EMR) data from October 01, 2005, to September 30, 2010. We obtained study protocol approvals from the Bedford VA Medical Center and the VA Boston Healthcare System Institutional Review Boards.
Data Sources
We acquired hospital discharge data (demographics, diagnoses and procedures, and discharge status) and outpatient visit diagnoses from the VA's National Patient Care Database and death dates from VA Vital Status Files. 13 We accessed VA-wide EMR data using VistaWeb.
14 In addition, we used CMS MedPAR files for selected sensitivity analyses.
Study Sample
Using CMS methods, we identified all VA index discharges with a principal diagnosis of AMI or HF during FY07 through FY10 associated with a VA readmission within 30 days. 4, 5, 10 An index discharge was a discharge in which the subsequent 30 days was assessed for a readmission. 4 A readmission was defined as the first VA acute care hospitalization occurring within 30 days post index discharge. 4 We followed CMS exclusions (other than age <65 years.) 4, 5 We kept discharges eligible for the CMS measure but considered ineligible by the 3M-PPRS (eg, admissions for major or metastatic malignancy 7 ; these are excluded because they require "follow-up care that is intrinsically clinically-complex, and …preventability is difficult to assess." 7 Of 33 423 index AMI discharges, 4986 (14.9%) had a readmission; respective numbers for HF were 93161 and 16 838 (18.1%; Figure 1A and 1B).
Next, using the 3M-PPR software (version 28.0), we flagged readmissions as a PPR (Yes/No; the latter group included PPR-ineligible cases). For each cohort, we randomly chose 300 index discharges associated with a 30-day readmission for potential EMR abstraction, our goal being full review of 100 cases. (We expected to exclude additional cases during chart abstraction such as those representing coding errors, or with CMS-intended exclusions missed by the VA administrative data, and that might make assessing care before readmission difficult [eg, transfers out to a non-VA hospital].) Assuming a standard deviation of 10 for the quality score of 0 to 100 and a 0.05 significance level, a sample size of 100, consisting of 75 PPR-Yes cases and 25 PPR-No cases provided ≈80% power to detect a 65% standard deviation difference (ie, a 6.5-point difference) in quality scores between PPR groups. This difference would be considered between a medium to large effect size (ES; see below) and is above the 50% standard deviation difference commonly used to discriminate change.
15,16
Development of Explicit Process Criteria
The method for developing explicit process criteria representing standards of care for AMI and HF mirrors that previously used for our
WHAT IS KNOWN
• The 3M-PPR software matches clinically related index admission and readmission diagnoses that may signify in-hospital or postdischarge quality problems.
• Little is known about the extent to which these matched admissions-readmissions signal deficiencies in quality or processes care and are thus potentially preventable.
• Nevertheless, state Medicaid programs are increasingly implementing the 3M-PPR for public reporting and hospital payment.
WHAT THE STUDY ADDS
• Among AMI and HF readmissions, we found no differences in case-level quality of care between those flagged as PPRs compared with those not flagged, as assessed using medical record review.
• Future studies should determine whether the 3M-PPR software is better at identifying preventable readmissions if other methods are used to assess poorly documented potentially important processes, or if other groups (ie, different cohorts of patients or different facilities) are compared.
pneumonia cohort and is based on the RAND/UCLA Appropriateness Method. 17 This is described in detail elsewhere. 12 Figures 2A and 2B shows the steps involved in developing AMI and HF criteria, respectively. These were performed separately for each condition. Briefly, we grouped candidate criteria obtained from the literature review (Appendix I in the Data Supplement) and clinical investigator input into 4 sections: (1) admission work-up, (2) in-hospital evaluation and treatment, (3) discharge readiness (clinical stability at discharge) and planning, and (4) postdischarge period. 18, 19 Next, an expert panel helped refine criteria by rating individual items on the extent to which they thought they represented the standard of AMI or HF care, as applicable, using a 7-point scale (1=strongly disagree, 7=strongly agree) and 2 rounds of rating. Four internists and 3 cardiologists served as the AMI panel and 5 internists and 2 cardiologists as the HF panel. By this process, we kept 124 AMI and 110 HF items, those with strong agreement (median ≥6.0 and no rating <5) plus those with a median score ≥6.0 and only 1 rating <5.
Tool Development/Medical Record Abstraction
We incorporated clinical items into condition-specific abstraction tools if they could be converted to if/then statements to assess quality of care. (If/then statement examples are available in Appendix II and Table I in the Data Supplement.) Tools also included case ascertainment items (ie, the case had to fit a standard clinical definition of AMI or HF). 20, 21 For HF, we used the modified Framingham clinical criteria, supplemented by radiographic items from the Boston Criteria and accepted brain natriuretic peptide or N-terminal pro-brain natriuretic peptide parameters. [21] [22] [23] [24] We also collected information on risk factors, disease severity, and cardiology involvement in care. The latter item was not an explicit process criterion identified by our clinical panel.
Two trained nurse-abstractors reviewed EMRs. After piloting the tools on 5 records, we found abstraction times were >3 hours in some cases. To keep abstraction times manageable, we excluded cases from abstraction with a length of stay longer than the 90th percentile (>14 days for AMI and >11 days for HF.) We also dropped items that were present in all cases and considered routine care (eg, having a complete blood count performed on admission), present in few cases (eg, functional status documentation), difficult to operationalize as a quality criterion (eg, at the follow-up provider visit, plans for addressing abnormal test results should be documented including justification if there was no change in plans), or time consuming to abstract/of low reliability (eg, "If a medication was changed on the day of discharge, then postdischarge follow-up was arranged within 7 days." In our pneumonia study, we frequently found discrepancies in documentation of admission medications or in-hospital changes depending on the source reviewed making this time consuming to assess and of low inter-rater reliability). 12 We also dropped several items pertaining to admission history documentation (eg, documentation of chest pain or symptoms suggestive of an anginal equivalent) because previous work showed no association between admission documentation and readmissions. Randomly Selected Index-Readmission Cases for Review, n=300
Reviewed Cases, n=138
Fully Reviewed Cases, n=100 Partially Reviewed Cases, n=38 Reasons not fully abstracted:
• Readmission for planned test/ treatment, n=9
• HF admission to non-VA hospital in prior 30 days, n=8
• Diagnosis not HF (coding error), n=5
• Readmission to a non-VA before specified VA readmission date, n=4 Nurses reviewed 161 AMI and 138 HF cases to obtain 100 fully abstracted cases per condition. The most common reason for exclusion from full abstraction for AMI was because of transfer out to a non-VA hospital (n=23); for HF, this was because of readmissions for a planned test or treatment (n=9; Figure 1A and 1B) For medications that should be given during admission or discharge, we listed standard contraindications in the abstraction tool but allowed a write-in for other. The lead clinical investigator (A.B.) reviewed write-ins for appropriateness. For AMI, she also reviewed cardiac catheterization reports as applicable (in consultation with D.B.) and reasons for lack of revascularization or only partial revascularization to address questions pertaining to appropriate risk stratification at discharge. Because there was some judgment involved in determining the appropriate cases needing further risk stratification, this was incorporated into our sensitivity analyses (see Sensitivity Analyses [item 2] section of this article.)
Analyses
We conducted separate but similar analyses for each condition. We compared fully abstracted cases with all VA AMI/HF discharges with a 30-day readmission by demographics and selected Elixhauser comorbidities (using administrative data-derived outpatient and inpatient diagnostic codes from 12 months pre index plus the index admission), length of stay, and time to readmission. 25 In addition, we compared PPR-Yes and PPR-No cases on these same variables, plus selected EMR-abstracted comorbidities. We used parametric and nonparametric tests as appropriate (t tests, χ 2 , and Wilcoxon ranksum) for both sets of comparisons.
Baseline Analyses
We examined mean quality scores by PPR status as follows: (1) We scaled scores, based on achievement of specified items (yes/no), to a maximum of 25 per section and summed scores across sections (maximum obtainable quality score=100; equal section weights). (2) We weighted individual items equally (regardless of section) and scaled total scores out of 100 (ie, total score=[number of items achieved/83 items]×100; equal item weights). Higher scores indicate more process of care items achieved and thus higher quality.
Sensitivity Analyses
We performed numerous sensitivity analyses: (1) We weighted items based on the mean panel rating of the item and then reran quality score methods 1 and 2 above. (2) We re-examined baseline findings by modifying items either with respect to the original numerator or denominator specification or deleting items with low achievement rates. For example, for the item, "the patient is ready for discharge if the creatinine closest to discharge is stable or falling compared to the admission value," we modified the numerator to require a decrease ≥20%. (3) Since 51% of all VA patients and 93% of those ≥65 years are dually enrolled in VA and Medicare, 26 we examined the frequency of postdischarge Medicare use by PPR status among our abstracted sample and assessed its potential effect on results, using CMS MedPAR files.
We examined the quality score-PPR status association further using a multivariate logistic regression model predicting PPR status by overall equal section weights score, adjusted for age, race, sex, and number of Elixhauser comorbidities. 25 We repeated this using the equal item weights score and individual section scores.
Finally, we examined quality score and time-to-readmission associations to assess the construct validity of our methods. We hypothesized that patients who experienced more quality of care problems would be readmitted sooner. For the full abstraction samples, we produced descriptive statistics of time-to-readmission intervals (0-3, 0-7, 0-14, and 0-30 days) by quality score and examined quality score by readmission time using simple correlation, plus linear regression adjusting for age, sex, race, and number of comorbidities. In addition, we re-examined quality scores by PPR status using 7-and 14-day readmission intervals. We conducted these analyses using (1) total quality score with equal section weights, (2) individual section scores (scaled out of 25), and (3) total score minus section D, as one would expect more occasions to satisfy section D criteria the more remote from index discharge.
We compared PPR group scores using t tests. We also calculated ES, which is independent of sample size, for selected results to characterize their clinical significance. 16 (Cohen defines ES of 0.2, 0.5, and 0.8 as small, medium, and large, respectively.) For multivariate logistic analyses, we examined odds ratios and 95% confidence intervals.
Results
Of fully abstracted AMI cases, 77% were flagged as PPRYes versus 81% of all 4986 AMI readmissions. Respective Figure 2 . A, Development of explicit acute myocardial infarction (AMI) process of care criteria. B, Development of explicit heart failure (HF) process of care criteria. *We also abstracted EMR information to ascertain the diagnosis of AMI or HF as applicable, plus information on risk factors and severity of illness. These were not included in the list of process of care criteria that comprised the quality of care score. Table 1 shows all AMI/ HF readmissions versus fully abstracted readmissions. For both AMI and HF, the all readmissions group had slightly more comorbidities although this difference was significant only for the HF sample. At the individual comorbidity level, there were no significant differences. For fully abstracted readmissions, Table 1 shows PPR-Yes and PPR-No characteristics. Although both AMI and HF had a higher percentage of whites and lower percentage of blacks in the PPR-Yes versus the PPR-No sample, this difference was significant only for the HF sample; time to readmission was shorter for both AMI and HF in PPR-Yes cases, but this difference was only significant for AMI. When examining EMRabstracted comorbidities, for both AMI and HF, there were no significant differences. Using administrative data, there was a nonsignificant trend toward more comorbidities in the PPR-Yes versus PPR-No cohorts for both discharge cohorts; individual comorbidity differences were also nonsignificant (data not shown for individual comorbidities). Essentially, all patients with AMI received cardiology care; for HF, fewer PPR-Yes versus PPR-No cases received cardiology care (34% versus 50%) but differences were not significant. Appendix III in the Data Supplement shows PPR reasons among abstracted cases.
For AMI, PPR-No cases had higher achievement rates than PPR-Yes cases on 34 of 83 process criteria (41%), whereas PPR-Yes cases did better on 27 criteria (33%). For HF, PPR-Yes cases had higher achievement rates on 35 of 83 process criteria (42%), whereas PPR-No cases did better on 31 criteria (37%).
For both AMI and HF, total baseline quality scores were slightly higher using the equal item weight method versus the equal section weight method (70.4±6.4 versus 61.4±10.7 for AMI and 68.3±7.5 versus 61.5±10.3 for HF) mainly because section D (postdischarge period) scores were low and contained only 22% and 20% of the items for AMI and HF, respectively. For both methods, total scores were not significantly different between AMI PPR-Yes and PPR-No cases, and ES were small (<0.20) for total scores and individual section comparisons (respective total equal item weight scores were 70.5±6.6 versus 70.2±5.5; P=0.47; ES=0.04). For HF, again by both methods, total scores were not significantly different, and ES were small when comparing PPR-No versus PPR-Yes cases (respective total equal item weight scores were 68.2±7.8 versus 68.9±5.4; P=0.76; ES=0.10). Among HF section comparisons, although differences were not significant, PPR-No cases had higher scores for sections C (discharge readiness/discharge planning) and D, with associated with scores midway between small and medium ES (ie, 0.39 and 0.35, respectively; Table 2 ).
Sensitivity Analyses
We obtained similar results when using panel weighted items, and no item modifications or deletions had any meaningful impact on findings (data not shown; available from authors; see Appendix IV, Table I , and page 24 for additional details in the Data Supplement).
Potential Medicare Use Impact
Of the AMI sample, 7% had Medicare outpatient claims between index discharge and readmission, representing 8% (n=6) of PPR-Yes and 4% (n=1) of PPR-No cases (P=1.0). Respective HF sample numbers were 9%, 9% (n=8), 7% (n=1), (P=1.0). Removing either section D or cases receiving non-VA postdischarge care did not alter findings.
Quality Scores as PPR Status Predictors
Logistic models adjusted for demographics and comorbidities did not show a significant association between quality score and PPR status (all confidence intervals included 1.0; Table 3 ).
For the full samples, quality scores were higher the longer the readmission interval. This trend was most evident for total score and section D, but remained for HF even with section D removed, and was significant by correlations and multivariate regression modeling for both cohorts (Appendix IV and Tables IIA and IIB in the Data Supplement). Quality scores by PPR status comparisons using 7-or 14-day readmission windows were similar to 30-day results. For AMI, PPR-Yes scores were higher than PPR-No cases; for HF, PPR-No scores were higher. Notably, associated ES were larger, especially for the 7-day window, with several differences of at least of medium clinical significance (Appendix IV, Figure 1A and 1B, and Tables IIIA and IIIB in the Data Supplement).
Discussion
Among VA readmissions after either an AMI or HF discharge, we found no significant association between quality of care, measured by adherence to selected processes of care received during the index admission and postdischarge, and potential preventability of a readmission, as designated by the 3M-PPRS, although HF quality scores were slightly lower among PPR-Yes cases.
Notably, both CMS and 3M-PPRS measures are meant for hospital-level comparisons of risk-adjusted rates. Despite this, we think that an individual case-level analysis is informative. Although both measures use different methods to control for comorbidity, both assume that once these key determinants of readmission are controlled for, high rates must result, in part, from unmeasured modifiable factors like quality of care. 4, 5, 7 Therefore, to reduce rates, a high outlier hospital by either measure would have to drill down to the individual patient-level to identify quality of care issues. The 3M-PPR software attempts to improve on the CMS measure by maximizing identification of preventable readmissions (ie, those with quality of care problems) by matching clinically related admissions and readmissions. 7 Across study cohorts, we found no significant statistical differences between cases flagged as PPRs and nonflagged cases although when examining clinical significance, ES findings were more mixed. For AMI, all ES were small. For HF, some ES were midway between small and medium, with the association in the expected direction (lower scores in PPR-Yes cases). Although PPR-Yes cases should be associated with more quality of care problems than PPR-No cases, the weaker association among AMI than HF patients may have been because of more uniform care in the former group given almost all were cared for by cardiologists. In our previous pneumonia study, we actually found slightly higher scores in the PPR-Yes cases although differences were similarly not significant; ES were between small and medium. 12 Therefore, our findings suggest that although the 3M-PPRS conceptually is an attractive alternative to CMS' all-cause readmission measure, it is no different in determining which individual cases are preventable. Consistent with the existing literature, most of our readmissions were flagged as PPRs and therefore deemed potentially preventable based on administrative codes; PPR rates from other studies range from 54% to 83% (median 75%) of readmissions depending on the cohort. 3, 8, 9, 28 However, chart review estimated preventable readmission rates are generally much lower (ie, 5%-79%, with a median of only 27%). 6 Jackson et al 28 recently conducted a case-level analysis, comparing 3M-PPRS with clinical judgment. By triangulating EMR review, interviews with treating providers and with a subset of patients and their caregivers, 29 they judged 47% of readmissions as potentially preventable versus 78% by the 3M-PPRS. 28 They concluded that agreement between methods was inadequate to replace clinical review. 28 Others have also expressed concerns that the 3M-PPRS does not flag truly preventable readmissions when examined at the case level. 30 Notably, even though chart review is considered superior to administrative data for preventability assessment, there is no true gold standard for determining whether a readmission is avoidable or not. Most studies assessing preventability, including that by Jackson et al, 28 primarily use implicit review that relies on judgment and is difficult to reproduce. 29, 31 To *Our administrative data set did not contain race. †Significant differences (ie, P<0.05) between groups. (There were no significant differences between not fully abstracted and abstracted readmissions.) ‡Derived from the APR-DRGs that classify patients according to their admission reason and severity of illness. Severity of illness level is APR-DRG specific and incorporates patient age, principal diagnosis, secondary diagnoses, and procedures from the index admission. 27 §Consists of 29 Elixhauser comorbidities obtained from administrative data (both inpatient and outpatient) from year prior up to and including the index admission. avoid making subjective judgments about preventability, we intentionally measured quality of care using detailed explicit processes of care to improve the reliability and generalizability of our findings; we also focused on items potentially more readily modifiable by a hospital, consistent with the premise behind the PPRs. Because we were trying to determine whether the 3M-PPRS measure was better at identifying preventable readmissions than an all-cause measure, we examined only readmitted patients. To our knowledge, there is only one other study using explicit quality of care that used a similar approach and similar discharge cohorts. 32 Weissman et al 32 examined the association between inpatient quality of care for patients with HF and potentially preventable 60-day readmissions. These were defined as "related adverse readmissions" based on clinician panel assessment of paired readmission diagnoses and readmission periods. Although criteria included those related to the admission history, treatment/evaluation, and discharge readiness/stability, items were categorized slightly differently and a single score was used. 32 Similar to our findings, overall explicit quality scores in patients with related adverse readmissions were comparable to other readmitted patients with HF. 32 It is possible that explicit EMR review may not be sensitive enough to assess quality of care and potential preventability. 31, 33 It requires complete and accurate documentation of care and may not reflect errors in care such as those because of misdiagnosis. Moreover, certain processes, such as those related to patient-provider communication, may be difficult to accurately document, requiring other data collection methods, such as direct observation. Further complicating the picture is the fact that although both AMI and HF have well-established evidence-based processes shown to improve mortality or decrease readmissions in randomized trials, 34, 35 processoutcome links have been harder to demonstrate in observational studies, particularly with respect to readmissions, even when comparing admitted with nonreadmitted patients. More consistent associations have been reported, especially for HF, when aggregating a large number of processes of care into a single score or multiple scores representing different stages of the hospital stay (as we have used) rather than using individual evidence-based process measures. 18, 32, 36, 37 The preceding issues illustrate the difficulty in assessing preventability. Any relevant administrative measure likely overestimates preventability; beyond requiring accurate coding, it lacks important clinical details required for such assessments and does not provide hospitals with actionable information required to decrease readmissions. Conversely, although chart review can provide actionable information, it is a labor intensive and still may not represent a true gold standard for assessing quality of care and preventability. In addition, readmissions result from various causes, including those that are not modifiable by the hospital (eg, socioeconomic factors). 38, 39 Whether the 3M-PPRS is more useful in certain discharge cohorts such as patients with HF, in terms of identifying quality improvement targets, requires further investigation. This is one of few studies to examine whether the PPR algorithm distinguishes preventability at the individual caselevel using detailed EMR-abstracted explicit processes of care and including postdischarge care. We used a rigorous well-established consensus method for criteria development and have condition-specific sets of process criteria that may be used by other groups. Further study strengths include the use of the VA EMR, allowing us to assess an extensive range of inpatient and outpatient processes VA-wide, and performance of multiple sensitivity analyses, which showed consistent findings.
We also had a few limitations: (1) our sample size was too small to detect small differences in the quality score as statistically significant. Thus, we also report ES that are independent of sample size. (Therefore, if we had a larger sample, we might find quality scores to be significantly higher among HF PPR-No cases but ES would be the same.) (2) It is unclear whether low postdischarge scores indicated lack of VA care or poor EMR documentation of care received. (3) We lacked information on non-VA EMR postdischarge care. However, for both items 2 and 3, exclusion of postdischarge care did not alter results. Although we did not include cases with non-VA hospital readmissions in our cohort, we have no All models adjusted for age, sex, race, and number of Elixhauser comorbidities (consists of 29 comorbidities obtained from inpatient and outpatient administrative data from year prior up to and including the index admission.) 25 AMI indicates acute myocardial infarction; HF, heart failure; and PPR, Potentially Preventable Readmissions.
reason to suspect any difference in findings if we had. (4) We did not abstract processes on management of active comorbidities (eg, diabetes mellitus). (5) Although we used a wellestablished consensus method, criteria reproducibility and associated weights may vary by clinical panel. 40 (6) In deriving our final set of process criteria, we made some decisions that might have affected our findings. We dropped certain criteria that were hard to find in the EMR although this was primarily limited to items not clearly linked to readmission (eg, whether functional status was documented). However, we also dropped some additional items because they were time consuming to obtain or difficult to operationalize. (7) As noted, we examined the 3M-PPRS at the patient level. It is still possible that the software may perform better at the hospital level in discriminating among facilities with respect to performance.
Conclusions
PPR classification using the 3M-PPRS was not associated with adherence to processes reflecting quality of care received during the index admission or postdischarge period among AMI and HF readmissions. Despite seeming like a fairer measure for assessing hospital performance, the 3M-PPRS does not provide additional benefit beyond an allcause readmission measure for helping providers target quality of care problems at the individual case-level especially for patients with AMI. Future studies should determine whether the 3M-PPRS is better at identifying preventable readmissions if additional methods beyond EMR review are used to assess poorly documented potentially important processes, or whether analyses performed in other discharge cohorts, or at the hospital level might show different results. For now, local efforts to reduce readmissions should continue to focus on optimizing adherence to evidence-based processes of care for all relevant patients.
